Hypermethylation of the DAPK1 gene promoter is associated with poor prognosis in lung cancer patients, with methylation-positive patients-defined as those exhibiting promoter hypermethylation-having significantly shorter progression-free survival and overall survival compared to methylation-negative patients (282, 283). The gene discussed is DAPK1; the disease is lung cancer.